Search results
Showing 7306 to 7320 of 7707 results
Repotrectinib for treating ROS1-positive advanced non-small-cell lung cancer [ID6277]
In development [GID-TA11302] Expected publication date: TBC
In development [GID-TA11007] Expected publication date: TBC
Tafamidis for treating transthyretin amyloidosis with cardiomyopathy (TA696)
This guidance has been updated and replaced by NICE technology appraisal guidance 984.
In development [GID-TA11475] Expected publication date: TBC
In development [GID-TA11301] Expected publication date: TBC
In development [GID-TA11588] Expected publication date: TBC
Venglustat for treating gangliosidoses in people 2 years and over [ID6358]
Discontinued [GID-TA11396]
PICO negative pressure wound therapy for closed surgical incision wounds (MIB149)
This advice has been updated and replaced by NICE medical technologies guidance 43.
QAngio XA 3D/QFR imaging software for assessing coronary obstructions (MIB146)
This advice has been updated and replaced by NICE diagnostics guidance 43.
This medtech innovation briefing (MIB) has been updated and replaced by NICE diagnostics guidance 41.
Point-of-care creatinine tests before contrast-enhanced imaging (MIB136)
This advice has been replaced by NICE diagnostics guidance 37.
In development [GID-TA10826] Expected publication date: TBC
Fordadistrogene movaparvovec for treating Duchenne muscular dystrophy [ID6133]
In development [GID-TA11044] Expected publication date: TBC
Capivasertib with paclitaxel for untreated metastatic triple-negative breast cancer [ID6383]
In development [GID-TA11411] Expected publication date: TBC
Azacitidine for treating relapsed or refractory angioimmunoblastic T-cell lymphoma [ID3864]
Discontinued [GID-TA10750]